This page is historical material reflecting the Feedback Loop Blog as it existed on
May 8, 2020. This page is no longer updated and links to external websites
and some internal pages may not work.
May 8, 2020
Because many people in the research community are facing considerable challenges trying to juggle various responsibilities during the COVID-19 outbreak, NIGMS will accommodate late application submissions for due dates in May 2020 for all NIGMS-specific FOAs (see NOT-GM-20-029). For applications submitted through June 30, 2020, institutions do not need to request advance permission or provide a cover letter to justify a late submission to these FOAs. Applications with due dates prior to May 25 should use FORMS E and those with due dates on or after May 25 should use FORMS F, regardless of the date of submission.
CURRENT NIGMS FUNDING ANNOUNCEMENTS IMPACTED BY THIS POLICY:
Title
FOA Number
Applicable Application Due Date
Applicable Forms Package
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
5/18/2020
FORMS E
IDeA Networks of Biomedical Research Excellence (INBRE) (P20 - Clinical Trial Optional)
5/20/2020
FORMS E
Maximizing Access to Research Careers (T34)
5/21/2020
FORMS E
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)
5/21/2020
FORMS E
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
5/21/2020
FORMS E
National Institute of General Medical Sciences Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant (T32)
5/25/2020
FORMS F
Medical Scientist Training Program (T32)
5/25/2020
FORMS F
Support of Competitive Research (SCORE) Research Continuance Award (SC3 - Clinical Trial Not Allowed)
5/25/2020
FORMS F
Support of Competitive Research (SCORE) Pilot Project Award (SC2 - Clinical Trial Not Allowed)
5/25/2020
FORMS F
Support of Competitive Research (SCORE) Research Advancement Award (SC1 - Clinical Trial Not Allowed)
5/25/2020
FORMS F
Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed)
5/26/2020
FORMS F
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
5/27/2020
FORMS F
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 - Clinical Trial Optional)
5/28/2020
FORMS F
NIH’s late application submission policy for institutions closed due to the effects of COVID-19 (NOT-OD-20-082) still applies to these FOAs for institutions that aren’t able to submit by June 30 and will be considered on a case-by-case basis. As much as NIGMS would like to extend flexibility further, this rapidly evolving situation creates multiple challenges for conducting both initial peer review and advisory council review by January 2021. Therefore, applicants should assume that late applications submitted after June 30, 2020, may not be reviewed for the current council round.
Please direct all inquiries to NIGMS_DEA_Mailbox@nigms.nih.gov.
About the Authors
Stephanie Constant
Before moving to the NIH Office of the Director in April 2023, Stephanie was chief of the NIGMS Scientific Review Branch. She oversaw the peer review of a broad range of research, training, education, and center grant applications assigned to NIGMS.
Erica Brown
As director of the Division of Extramural Activities, Erica oversees the peer review and fiscal management of NIGMS grants and advises staff on the planning, development, and administration of Institute grant programs.